# Encompass Health Corporation (EHC) Stock Analysis: A Strong Buy with 26.5% Potential Upside

- Link: https://www.directorstalkinterviews.com/encompass-health-corporation-ehc-stock-analysis-a-strong-buy-with-26-5-potential-upside/4121259002
- Published: 2026-08-03T10:25:24+01:00
- Author: Madison Wilson

Encompass Health Corporation (NYSE: EHC) stands as a formidable player in the healthcare
sector, specifically within the medical care facilities industry. Operating primarily
in the United States and Puerto Rico, the company specializes in inpatient rehabilitation
hospitals, providing crucial rehabilitative treatment to patients recovering from
significant injuries or illnesses. Based in Birmingham, Alabama, Encompass Health’s
comprehensive service offerings cater to patients recovering from a range of conditions,
including neurological disorders, cardiac issues, and complex orthopedic injuries.

The company boasts a robust market capitalization of $11.02 billion, reflecting 
its significant presence in the industry. Currently priced at $111.07, Encompass
Health’s stock has demonstrated stability within its 52-week range of $93.83 to 
$127.18. Despite a modest price change of 0.18 (0.00%) recently, the stock’s performance
metrics reveal a compelling investment opportunity.

One standout feature for investors is Encompass Health’s revenue growth, which is
reported at an impressive 9.00%. This growth is complemented by a notable earnings
per share (EPS) of 5.84 and a return on equity (ROE) of 25.23%, underscoring the
company’s efficiency in generating profits from its equity base. Furthermore, the
company has a solid free cash flow of approximately $284.1 million, providing a 
strong foundation for future investments and potential dividends.

Speaking of dividends, Encompass Health offers a dividend yield of 0.76% with a 
conservative payout ratio of 12.67%, suggesting a sustainable dividend policy that
balances rewarding shareholders and reinvesting in growth opportunities.

From an analyst perspective, Encompass Health receives unanimous support, with 13
buy ratings and no hold or sell recommendations. This bullish sentiment is reinforced
by an average target price of $140.50, indicating a significant potential upside
of 26.50% from the current price. The target price range of $125.00 to $152.00 further
emphasizes the stock’s potential for growth.

Technical indicators provide additional insights into the stock’s momentum. The 
relative strength index (RSI) of 93.42 suggests the stock is currently overbought,
which could imply a near-term correction. However, the moving averages indicate 
a positive trend, with the 50-day moving average at $105.88 and the 200-day moving
average at $107.10, both supporting the stock’s upward trajectory. The MACD of 2.10,
against a signal line of 2.34, may suggest a potential shift in momentum, warranting
close monitoring by investors.

Encompass Health’s focus on specialized rehabilitative care positions it well within
the healthcare sector, particularly as demand for such services is poised to grow
with an aging population. The company’s strategic use of technology and therapy 
enhances its treatment offerings, aligning with modern healthcare trends and patient
needs.

For investors seeking a stable yet growth-oriented healthcare stock, Encompass Health
Corporation presents a compelling case. Its strong financial performance, supported
by analyst confidence and a promising upside potential, makes EHC a noteworthy consideration
for those looking to diversify their portfolios with a focus on the healthcare industry.

Share on:
